학술논문
Sunitinib‑induced small bowel wall edema as a prognostic marker in metastatic renal cell carcinoma.
Document Type
Article
Author
Source
Subject
*RENAL cell carcinoma
*SMALL intestine
*PROGNOSIS
*SUNITINIB
*EDEMA
*
*
*
*
Language
ISSN
0973-1482
Abstract
Aim: The aim of this study was to evaluate the presence of small bowel wall edema (SBWE) on computed tomography(CT) images in patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib and to investigate the relationship between the presence of SBWE and survival. Materials and Methods: We retrospectively evaluated the presence of SBWE on CT images of 27 mRCC patients who received at least one cycle of sunitinib. Then, we analyzed the relationship between the presence of SBWE and progression‑free survival (PFS) and overall survival (OS). Results: All 27 patients had SBWE on at least one CT scan. The median value of SBWE thickness was 2.5 mm. SBWE thickness was ≤2.5 mm in 13 patients (group A) and >2.5 mm in 14 patients (group B). The median OS was significantly higher in group B (55 vs. 18 months, respectively, P = 0.02). Although it was not statistically significant (13 vs. 8 months, respectively, P = 0.69), the median PFS was longer in group B than in group A. Conclusions: This study showed that sunitinib treatment caused SBWE in all patients with mRCC who received the drug. Also, this study demonstrated an association between higher SBWE thickness and better survival outcomes. [ABSTRACT FROM AUTHOR]